From Medscape HIV/AIDS

Coverage from the

International AIDS Society (IAS) 2017 Conference

July 23 - 26, 2017; Paris, France

July 23 - 26, 2017 Paris, France

Conference News

Popular News from AIDS 2016

  • Long-Acting Injectable Antiretroviral Safe, Effective Long-Acting Injectable Antiretroviral Safe, Effective The first long-acting injectable antiretroviral regimen is safe and effective at 48 weeks, and patients find it very convenient, new research suggests.
  • HIV Vaccine Trial Gets Green Light HIV Vaccine Trial Gets Green Light Immune responses to candidate HIV vaccines in a South African population were so robust that a large phase 2b/3 efficacy trial will be launched.
  • Latest HIV Cure Data Expose Resilience of Infection Latest HIV Cure Data Expose Resilience of Infection Disappointing results from SEARCH 19 and other recent studies are a challenge for researchers, who must balance progress with the fact that most patients are doing well on antiretroviral therapy.

Medscape HIV/AIDS©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

 

Previous Coverage

www.pillsbank.net

Левитра 60 мг

levitra generico en farmacias españolas